Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/61734
Type
ArticleCopyright
Open access
Sustainable Development Goals
05 Igualdade de gêneroCollections
- INI - Artigos de Periódicos [3648]
Metadata
Show full item record6
CITATIONS
6
Total citations
6
Recent citations
n/a
Field Citation Ratio
n/a
Relative Citation Ratio
INTIMATE PARTNER VIOLENCE AMONG BRAZILIAN TRANS AND CISGENDER WOMEN LIVING WITH HIV OR AT HIV RISK DURING COVID-19 ERA: ANOTHER EPIDEMIC?
Author
Rafael, Ricardo de Mattos Russo
Jalil, Emilia M.
Velasque, Luciane de Souza
Friedman, Ruth Khalili
Ramos, Michelle
Cunha, Cynthia B.
Peixoto, Eduardo Mesquita
Andrade, Lívia Machado de Mello
Depret, Davi Gomes
Gil, Adriana Costa
Alcântara, Dandara Costa
Monteiro, Laylla
Knupp, Virginia Maria de Azevedo Oliveira
Veloso, Valdiléa G.
Wilson, Erin C.
Grinsztejn, Beatriz
Jalil, Emilia M.
Velasque, Luciane de Souza
Friedman, Ruth Khalili
Ramos, Michelle
Cunha, Cynthia B.
Peixoto, Eduardo Mesquita
Andrade, Lívia Machado de Mello
Depret, Davi Gomes
Gil, Adriana Costa
Alcântara, Dandara Costa
Monteiro, Laylla
Knupp, Virginia Maria de Azevedo Oliveira
Veloso, Valdiléa G.
Wilson, Erin C.
Grinsztejn, Beatriz
Affilliation
State University of Rio de Janeiro. College of Nursing. Department of Public Health Nursing. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro State. Department of Quantitative Methods. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro State. College of Nursing. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro State. Medical School. Rio de Janeiro, RJ, Brazil.
State University of Rio de Janeiro. College of Nursing. Department of Public Health Nursing. Rio de Janeiro, RJ, Brazil.
State University of Rio de Janeiro. College of Nursing. Department of Public Health Nursing. Rio de Janeiro, RJ, Brazil.
State University of Rio de Janeiro. College of Nursing. Department of Public Health Nursing. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro State. College of Nursing. Rio de Janeiro, RJ, Brazil / Federal University of the State of Rio de Janeiro. College of Nursing. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil.
Center for Public Health Research. San Francisco Department of Public Health. San Francisco, California, USA / University of California. Department of Epidemiology and Biostatistics. San Francisco, California, USA.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro State. Department of Quantitative Methods. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro State. College of Nursing. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro State. Medical School. Rio de Janeiro, RJ, Brazil.
State University of Rio de Janeiro. College of Nursing. Department of Public Health Nursing. Rio de Janeiro, RJ, Brazil.
State University of Rio de Janeiro. College of Nursing. Department of Public Health Nursing. Rio de Janeiro, RJ, Brazil.
State University of Rio de Janeiro. College of Nursing. Department of Public Health Nursing. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro State. College of Nursing. Rio de Janeiro, RJ, Brazil / Federal University of the State of Rio de Janeiro. College of Nursing. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil.
Center for Public Health Research. San Francisco Department of Public Health. San Francisco, California, USA / University of California. Department of Epidemiology and Biostatistics. San Francisco, California, USA.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil.
Abstract
Purpose: Our study was conducted to estimate intimate partner violence (IPV) prevalence and associated factors among trans and cisgender women at risk of or living with HIV during the coronavirus disease (COVID-19) pandemic in Rio de Janeiro, Brazil. Methods: A cross-sectional study was conducted between May and August 2020 through telephone surveys with cisgender and trans women enrolled in two cohort studies in Rio de Janeiro. We assessed IPV employing the Revised Conflict Tactics Scale during the initial months of shelter-in-place ordinances. Regression models evaluated the factors associated with IPV for each population. Results: We surveyed 796 women, and 341 participants (47.78%) were eligible and included in the current analysis. All cisgender women and 41 (64.06%) trans women were living with HIV. Overall IPV prevalence was 27.86% (95% confidence interval [95% CI] 23.34–32.88). IPV was 63% higher among trans women than among cisgender women (prevalence ratio 1.63, 95% CI 1.14–2.34, p = 0.008). Loneliness was significantly associated with IPV in both groups. Younger age and binge drinking were associated with IPV prevalence among trans women. For cisgender women, IPV was associated with withdrawal of cash transfer programs during the shelter-in-place. Conclusion: Trans women experienced significantly more IPV than cisgender women in the early phase of the COVID-19 epidemic. Plans to prevent and address violence against cisgender and trans women, especially those with heightened vulnerability that may be associated with living with HIV, are needed in public health planning for future pandemics.
Share